Indaptus Therapeutics prices $2.135M offering of stock and warrants at $1.175/unit

Indaptus Therapeutics, Inc.

Sold 1,817,017 shares of common stock and warrants to buy 1,817,017 shares at $1.175 per unit.
Warrants exercisable at $1.05/share, immediately exercisable, 5-year term; gross proceeds ~$2.135M.
CEO participating, purchasing 42,553 shares and warrants on same terms as other investors.
Funds to be used for R&D, working capital, and general corporate purposes.
Closing expected November 25, 2024; Paulson Investment Company acting as exclusive placement agent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.